Investors: Overview

Taylored Biotherapeutics is a microbiome therapeutics company focused on the research and development of new drugs to combat a variety of mental health illnesses. By leveraging our robust data platform, sophisticated machine learning technologies and patient-driven developmental pipeline, Taylored is coming up with new solutions for maintaining the well-being of the mind and body.

Taylored has partnered with Netramark, providing proprietary AI to optimize the path in new drug development, accelerate clinical trials, mitigate placebo response, and redefine the landscape of how disorders are treated. Additional partnerships have been made with the University of Calgary’s Innovate Calgary and the Canadian National Research Council’s Industrial Research Assistance Program (NRC-IRAP).

For investment information please contact us at Info@TayloredBio.com